Outpatient Heart Failure Management Common Problems Elaine Winkel, M.D. University of Wisconsin Heart Failure and Transplant Program.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Advertisements

Advanced Heart Failure and the Role of Mechanical Circulatory Support
Managing Chronic Heart Failure
Optimizing Treatment Of Heart Failure for individual patients By Prof. Mansoor Ahmad FRCP Consultant Cardiologist.
Chapter 20 Heart Failure.
HEART FAILURE: ANSWERS YOU NEVER GET TO QUESTIONS YOU ALWAYS ASK BART COX, M.D.FACC DIRECTOR, ADVANCED HEART FAILURE PROGRAM ASSOCIATE PROFESSOR OF MEDICINE.
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Congestive Heart Failure
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Diastolic Heart Failure, HFpEF, HFnEF: What are we treating anyway? Charles M. Rasmussen, MD FACC.
Congestive heart failure
By Dr. Figgins & Dr. Gausden.  Clinical syndrome resulting from inadequate cardiac output for the body’s needs.
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
1 Heart Failure William Chavey, MD, MS Associate Professor Department of Family Medicine University of Michigan.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Heart Failure: Living with a Hurting Heart. Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood.
Congestive Heart Failure Stephen Gottlieb, MD Professor of Medicine Director, Cardiomyopathy and Pulmonary Hypertension University of Maryland.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
© 2000 Heart Failure Society of America, Inc.
The Heart and Heart Failure in the Year 2013 Jonathan D. Rich, MD Associate Director, Mechanical Circulatory Support Program Bluhm Cardiovascular Institute.
Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, :40PM – 2:00PM ©AAHCM.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Pharmacological Therapy of Heart Failure: Case presentations Steven W. Harris MHS, PA-C.
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Drugs for Heart Failure
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Modern Management of heart Failure Dr Amanda Varnava Consultant Cardiologist Watford & St Mary’s Hospitals.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults p.o.box zip code Done by: Dr.Amin Zagzoog.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Heart Failure Hazel Phillips Cardiac Support Nurse Bedford Hospital NHS Trust.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Treatment of Heart Failure Claire Hunter, MD. Treatment of Heart Failure Goals Improve quality of life Prolong life Ejection fraction most important.
Heart Failure Management Applying the ACC/AHA Chronic Heart Failure Guidelines David Bragin Sánchez MD FACC Cardiomyopathy and Cardiac Transplant Specialist.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
HEART FAILURE.
Cardiac Failure Richard Price Richard Price Consultant, Intensive Care, RAH. Consultant, Intensive Care, RAH.
Nursing and heart failure
Heart Failure Heart is unable to pump sufficient blood to meet the needs of the body. It is key symptoms are dyspnea, fatigue, fluid retention. HF is.
Heart failure: The national burden AHA. Heart disease and stroke statistics–2005 update. Koelling TM et al. Am Heart J. 2004;147:74-8. VBWG Affects 1 million.
TREATMENT OF HEART FAILURE From Oral Medications to Intravenous Drips Mark Puhlman MSN ANP.
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
Heart Failure. Background to Congestive Heart Failure Normal cardiac output needed to adequately perfuse peripheral organs – Provide O 2, nutrients, etc.
Haissam A Haddad, MD, FRCPC, FACC University of Ottawa Heart Institute
Internal Medicine Workshop Series Laos September /October 2009
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Management of Heart Failure Dr. M.Kheir Mulki. What is the definition of Heart Failure ?
Heart Failure J. Lynn Davis, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April 25, 2015.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
The Cardiac Side of the Cardio-Renal Dilemma
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
Blake Wachter, MD, PhD Idaho Heart Institute. Heart Failure  Any structural or functional impairment of ventricular filling or ejection of blood  Symptoms.
HF diagnosis: audit of NTproBNP uptake and outcomes across Sheffield An update on diagnosis and management of HF Dr Abdallah Al-Mohammad, MD, FRCP(Edin),
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.

Chronic heart failure By Vishal Patel GPVTS1.
Drugs for Heart Failure
Dike Ojji Senior Lecturer
Heart Failure - Summary
Congestive heart failure
Section III: Neurohormonal strategies in heart failure
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
β-Blocker Use for the Stages of Heart Failure
The Heart Failure Nurse Service
Presentation transcript:

Outpatient Heart Failure Management Common Problems Elaine Winkel, M.D. University of Wisconsin Heart Failure and Transplant Program

Who takes care of heart failure patients? 75% -primary care 20%-cardiology 5%-heart failure cardiologist

Heart Failure LV systolic dysfunction with an ejection fraction of < 40 %

Heart Failure A syndrome characterized by left ventricular dysfunction, reduced exercise tolerance, impaired quality of life, and reduced life expectancy. Cohn

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

New Approach to the Classification of Heart Failure StagePatient Description A High risk for developing heart failure (HF) Hypertension CAD Diabetes mellitus Family history of cardiomyopathy B Asymptomatic HFPrevious MI LV systolic dysfunction Asymptomatic valvular disease C Symptomatic HFKnown structural heart disease Shortness of breath and fatigue Reduced exercise tolerance D Refractory end-stage HF Marked symptoms at rest despite maximal medical therapy (e.g., those who are recurrently hospitalized or cannot be safely discharged from the hospital without specialized interventions) Hunt SA et al. J Am Coll Cardiol. 2001;38:2101–2113.

Classification of HF: Comparison Between ACC/AHA HF Stage and NYHA Functional Class 1 Hunt SA et al. J Am Coll Cardiol. 2001;38:2101– New York Heart Association/Little Brown and Company, Adapted from: Farrell MH et al. JAMA. 2002;287:890–897. ACC/AHA HF Stage 1 AAt high risk for heart failure but without structural heart disease or symptoms of heart failure (eg, patients with hypertension or coronary artery disease) BStructural heart disease but without symptoms of heart failure CStructural heart disease with prior or current symptoms of heart failure DRefractory heart failure requiring specialized interventions NYHA Functional Class 2 IAsymptomatic IISymptomatic with moderate exertion IVSymptomatic at rest IIISymptomatic with minimal exertion None

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

Common Diagnostic Errors LV systolic dysfunction commonly a missed diagnosis No symptoms Symptoms attributed to other diseases Symptoms ignored Signs ignored (CXR)

Why screen for LV dysfunction? May be asymptomatic Mortality related to degree of LV dysfunction, not symptoms High mortality once symptoms appear

Heart failure is worse than most cancers. -The Fat Man The House of God -The Fat Man The House of God

Patients at risk for developing HF (Stage A) Coronary disease or CAD equivalent (DM) Hypertension Hyperlipidemia Congenital heart disease Valvular heart disease Stroke or other vascular disease –30% w/LVD Arrhythmias

High risk patients Drug abuse (cocaine, anabolic steroids) Alcohol use Family members with heart failure Sickle cell disease Sarcoidosis/amyloidosis Muscular dystrophies Collagen vascular diseases Immigrant population-Chagas

High risk patients End stage renal disease Chronic lung disease-(long time beta- agonist use) Certain malignancies (multiple myeloma) History of cardiotoxic drugs (adriamycin)

High risk populations Good history, including family history Screen with echocardiography

Diagnostic errors LV systolic dysfunction not completely evaluated No cardiac cath Incomplete echo study Role of endomyocardial biopsy

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

Common presentations of HF Fatigue SOB GI distress (anorexia, early satiety, abdominal bloating, nausea, vomiting) Chest pain/pressure Lightheadedness/dizziness/palpitations No symptoms

Physical Exam Often unhelpful especially in chronic or slowly progressive LV dysfunction Physical signs frequently absent History most important

Causes of SOB in patients with known LVD New or worsening CAD New or worsening valve disease Unappreciated arrhythmia Anemia Lung disease Deconditioning

Other causes of edema Cirrhosis Severe renal insufficiency Nephrotic syndrome Venous insufficiency Lymphedema

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

Current medical therapy ACE inhibitors/ARB’s/direct vasodilators Digoxin Diuretics Beta-blockers Aldosterone blockers

ACE Inhibitors-common errors Short vs. long acting agent Dose too low ARB substituted- (cough, creatinine rise, etc.) Asymptomatic patient w. LVD

Digoxin Not given Wrong dose Dig level Effect of amiodarone, spironolactone Digoxin in women

Diuretics Too much Too little Generic vs. brand name Timing

Beta Blockers Wrong time (concomitant w/ACE, decompensated, volume overloaded) Wrong agent (atenolol, acebutelol, pindolol, carvedilol vs. metoprolol) Wrong dose Using BB alone Asymptomatic patient w/LVD

Aldosterone Blockers Spironolactone vs. eplerenone Too much Wrong patient (nl-hi K+, DM, Type IV RTA, renal insufficiency, non-compliant) No follow-up

Drug management Drugs/doses used in clinical trials Generic vs. brand name drugs Short vs. long acting agents Pill bottles each visit Timing to avoid lightheadedness

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

Non-pharmacologic therapy Sodium restriction-2000 mg/day Fluid restriction Avoid alcohol Small, frequent meals Energy conservation

Deleterious drugs Calcium blockers-nefedipine, diltiazem, verapamil Antiarrhythmics NSAID’s, COX-2 inhibitors (inc OTC) Herbal agents (hawthorn, gingko, St. John’s wort) Grapefruit juice Inotropic agents-(milrinone, dobutamine)

Common Problems Diagnosis Physical assessment Drug therapy Non-pharmacologic therapy Education & follow-up Other therapies for heart failure

Education and follow-up Disease Treatment Diet/fluids Exercise/rest Avoid deleterious agents Involve family Close follow-up

Other therapies Coronary intervention (PCI, CABG) Ventricular reconstruction (aneurysm resection or Dor procedure) Valve repair or replacement Correction of arrhythmias-especially AF Pacing (DDD, BiV) ICD

“Genius is the infinite capacity for taking pains.” Sherlock Holmes